FDA Eyes AngioDynamics Over Surgical Knife Marketing

Law360, New York (January 27, 2011, 3:42 PM EST) -- AngioDynamics Inc. has received a warning letter from the U.S. Food and Drug Administration for allegedly marketing its surgical device NanoKnife for unapproved uses.

The Albany, N.Y.-based company revealed Tuesday that it had received the letter, which accused it of making certain statements, including on its website, that promote the use of the NanoKnife system beyond its currently cleared indications.

The NanoKnife system has been approved in the U.S. market and in certain international markets for the surgical ablation of soft tissue.

AngioDynamics said it is...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.